Give Now

Delays, Closings and Severe Weather - View All Alerts and Updates

Drug That Reduces Bad Cholesterol Won’t Be At Pharmacy Soon

An Indiana cardiologist says don't look for it to hit pharmacy shelves any time soon.

An experimental drug that claims to reduce bad cholesterol is getting a lot of attention, but an Indiana cardiologist says don’t look for it to hit pharmacy shelves any time soon. Dr. Douglas Zipes with the IU School of Medicine says the injection is actually an antibody that reduces bad cholesterol by affecting a certain function in the liver.

“I think that they’ve gotten the first stage done beautifully and that’s the initial hurdle, but it clearly needs a follow up of what we call outcomes research. Does it make a difference in the clinical state of the patient,” he says.

Dr. Zipes says while it has shown to affect cholesterol levels, it has not been tested to have any other effects like existing cholesterol drugs. He says current drugs have added benefits such as the prevention or reduction of inflammation.

Dr. Zipes says while the initial studies into the injections have shown promise, additional tests need to be done to see if there is any effect on outcome or other proof that the patient has benefits greater than or equal to current available medications that address cholesterol levels.

Want to contact your legislators about an issue that matters to you? Find out how to contact your senators and member of Congress here.

What is RSS? RSS makes it possible to subscribe to a website's updates instead of visiting it by delivering new posts to your RSS reader automatically. Choose to receive some or all of the updates from Indiana Public Media News:

Support For Indiana Public Media Comes From